Danaher Corp (DHR) - Former Life Sciences Revenue (I:DCDHRFLS)
Level Chart
Basic Info
|
Danaher Corp (DHR) - Former Life Sciences Revenue is at a current level of 4.118B, up from 3.59B last quarter and up from 3.901B one year ago. This is a change of 14.71% from last quarter and 5.56% from one year ago. |
|
Danaher Corp Former Life Sciences Revenue refers to the income generated by the company's business activities related to the life sciences sector, which includes products and solutions used in various fields such as biotechnology, pharmaceuticals, diagnostics, and research. |
| Report | Fiscal.ai |
| Category | Segments & KPIs |
| Region | United States |
| Source | Fiscal.ai |
|
Data provided via Fiscal.ai |
Stats
| Last Value | 4.118B |
| Latest Period | Dec 2025 |
| Last Updated | Mar 23 2026, 14:09 EDT |
| Next Release | Apr 15 2026, 08:30 EDT (E) |
| Average Growth Rate | 16.73% |
| Value from Last Quarter | 3.59B |
| Change from Last Quarter | 14.71% |
| Value from 1 Year Ago | 3.901B |
| Change from 1 Year Ago | 5.56% |
| Frequency | Quarterly |
| Unit | USD |
| Adjustment | N/A |
| Download Source File |
Historical Data
| Date | Value |
|---|---|
| December 31, 2025 | 4.118B |
| September 26, 2025 | 3.59B |
| June 27, 2025 | 3.627B |
| March 28, 2025 | 3.292B |
| December 31, 2024 | 3.901B |
| September 27, 2024 | 3.435B |
| June 28, 2024 | 3.483B |
| March 29, 2024 | 3.269B |
| December 31, 2023 | 3.689B |
| September 29, 2023 | 3.37B |
| June 30, 2023 | 3.681B |
| March 31, 2023 | 3.573B |
| December 31, 2022 | 4.169B |
| Date | Value |
|---|---|
| September 30, 2022 | 3.776B |
| July 01, 2022 | 3.967B |
| April 01, 2022 | 3.882B |
| December 31, 2021 | 4.046B |
| October 01, 2021 | 3.632B |
| July 02, 2021 | 3.734B |
| April 02, 2021 | 3.546B |
| December 31, 2020 | 3.361B |
| October 02, 2020 | 2.923B |
| July 03, 2020 | 2.642B |
| April 03, 2020 | 1.65B |
| December 31, 2019 | 1.916B |
News
Basic Info
|
Danaher Corp (DHR) - Former Life Sciences Revenue is at a current level of 4.118B, up from 3.59B last quarter and up from 3.901B one year ago. This is a change of 14.71% from last quarter and 5.56% from one year ago. |
|
Danaher Corp Former Life Sciences Revenue refers to the income generated by the company's business activities related to the life sciences sector, which includes products and solutions used in various fields such as biotechnology, pharmaceuticals, diagnostics, and research. |
| Report | Fiscal.ai |
| Category | Segments & KPIs |
| Region | United States |
| Source | Fiscal.ai |
|
Data provided via Fiscal.ai |
Stats
| Last Value | 4.118B |
| Latest Period | Dec 2025 |
| Last Updated | Mar 23 2026, 14:09 EDT |
| Next Release | Apr 15 2026, 08:30 EDT (E) |
| Average Growth Rate | 16.73% |
| Value from Last Quarter | 3.59B |
| Change from Last Quarter | 14.71% |
| Value from 1 Year Ago | 3.901B |
| Change from 1 Year Ago | 5.56% |
| Frequency | Quarterly |
| Unit | USD |
| Adjustment | N/A |
| Download Source File |
Related Securities
Related Indicators
| Danaher Corp (DHR) - Biotechnology Operating Income | 540.00M USD |
| Danaher Corp (DHR) - Biotechnology Revenue | 2.033B USD |
| Danaher Corp (DHR) - Core Sales Growth | 2.50% |
| Danaher Corp (DHR) - Diagnostics Operating Income | 713.00M USD |
| Danaher Corp (DHR) - Diagnostics Revenue | 2.72B USD |